Ninomiya Sho, Ishikawa Tatsuya, Takahashi Masayuki, Seki Mineaki, Nashimoto Masayuki
Research Institute for Healthy Living, Niigata University of Pharmacy and Applied Life Sciences, Niigata, Niigata, 956-8603, Japan.
Noncoding RNA Res. 2019 Nov 22;4(4):135-140. doi: 10.1016/j.ncrna.2019.11.003. eCollection 2019 Dec.
The 31- and 32-nt 5'-fragments of Y4-RNA (Y4RNAfr) exist abundantly in human plasma. The Y4RNAfr can function as 5'-half-tRNA-type sgRNA for tRNase Z, although we do not know yet what its physiological roles are and what cellular RNAs are its genuine targets. In this paper, we analyzed the effects of the Y4RNAfr on cell viability and transcriptomes using HL60, RPMI-8226, and HEK293 cells, and Y4RNAfr-binding RNAs in A549 cells. Although the Y4RNAfr hardly affected the viability of HL60, RPMI-8226, and HEK293 cells, it significantly affected their transcriptome. The DAVID analysis for > 2-fold upregulated and downregulated genes suggested that the Y4RNAfr may affect various KEGG pathways. We obtained 108 Y4RNAfr-binding RNAs in A549 cells, searched potential secondary structures of complexes between theY4RNAfr and its binding RNAs for the pre-tRNA-like structure, and found many such structures. One of the five best fitted structures was for the MKI67 mRNA, suggesting that the Y4RNAfr can decrease the cellular MKI67 level through guiding the cleavage of the MKI67 mRNA by tRNase Z. This may be one of the underlying mechanisms for the reported observation that the Y4RNAfr suppresses the proliferation of A549 cells.
Y4-RNA的31和32个核苷酸的5'-片段(Y4RNAfr)大量存在于人体血浆中。Y4RNAfr可作为tRNase Z的5'-半tRNA型sgRNA发挥作用,尽管我们尚不清楚其生理作用是什么以及其真正的细胞RNA靶标是什么。在本文中,我们使用HL60、RPMI-8226和HEK293细胞分析了Y4RNAfr对细胞活力和转录组的影响,并分析了A549细胞中与Y4RNAfr结合的RNA。尽管Y4RNAfr几乎不影响HL60、RPMI-8226和HEK293细胞的活力,但它对它们的转录组有显著影响。对上调和下调超过2倍的基因进行的DAVID分析表明,Y4RNAfr可能影响各种KEGG途径。我们在A549细胞中获得了108个与Y4RNAfr结合的RNA,搜索了Y4RNAfr与其结合RNA之间复合物的潜在二级结构以寻找前体tRNA样结构,并发现了许多这样的结构。拟合度最好的五个结构之一是针对MKI67 mRNA的,这表明Y4RNAfr可以通过引导tRNase Z切割MKI67 mRNA来降低细胞中MKI67的水平。这可能是所报道的Y4RNAfr抑制A549细胞增殖这一观察结果的潜在机制之一。